Zhang Y - Search Results

1

IL-33/ST2 as a potential target for tumor immunotherapy.

Jiang W, Lian J, Yue Y, Zhang Y. Jiang W, et al. Among authors: zhang y. Eur J Immunol. 2021 Aug;51(8):1943-1955. doi: 10.1002/eji.202149175. Epub 2021 Jun 23. Eur J Immunol. 2021. PMID: 34131922 Free article. Review.

2

Evaluation of diagnostic value in using a panel of multiple tumor-associated antigens for immunodiagnosis of cancer.

Wang P, Song C, Xie W, Ye H, Wang K, Dai L, Zhang Y, Zhang J. Wang P, et al. Among authors: zhang j, zhang y. J Immunol Res. 2014;2014:512540. doi: 10.1155/2014/512540. Epub 2014 Apr 13. J Immunol Res. 2014. PMID: 24822225 Free PMC article.

3

Selective depletion of regulatory T cell subsets by docetaxel treatment in patients with nonsmall cell lung cancer.

Li JY, Duan XF, Wang LP, Xu YJ, Huang L, Zhang TF, Liu JY, Li F, Zhang Z, Yue DL, Wang F, Zhang B, Zhang Y. Li JY, et al. Among authors: zhang b, zhang tf, zhang z, zhang y. J Immunol Res. 2014;2014:286170. doi: 10.1155/2014/286170. Epub 2014 Apr 28. J Immunol Res. 2014. PMID: 24868562 Free PMC article.

4

TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumors.

Spear TT, Callender GG, Roszkowski JJ, Moxley KM, Simms PE, Foley KC, Murray DC, Scurti GM, Li M, Thomas JT, Langerman A, Garrett-Mayer E, Zhang Y, Nishimura MI. Spear TT, et al. Among authors: zhang y. Cancer Immunol Immunother. 2016 Mar;65(3):293-304. doi: 10.1007/s00262-016-1800-2. Epub 2016 Feb 3. Cancer Immunol Immunother. 2016. PMID: 26842125 Free PMC article.

5

Reactive Oxygen Species Regulate T Cell Immune Response in the Tumor Microenvironment.

Chen X, Song M, Zhang B, Zhang Y. Chen X, et al. Among authors: zhang b, zhang y. Oxid Med Cell Longev. 2016;2016:1580967. doi: 10.1155/2016/1580967. Epub 2016 Jul 28. Oxid Med Cell Longev. 2016. PMID: 27547291 Free PMC article. Review.

6

Exogenous IL-33 Restores Dendritic Cell Activation and Maturation in Established Cancer.

Dominguez D, Ye C, Geng Z, Chen S, Fan J, Qin L, Long A, Wang L, Zhang Z, Zhang Y, Fang D, Kuzel TM, Zhang B. Dominguez D, et al. Among authors: zhang b, zhang z, zhang y. J Immunol. 2017 Feb 1;198(3):1365-1375. doi: 10.4049/jimmunol.1501399. Epub 2016 Dec 23. J Immunol. 2017. PMID: 28011934 Free PMC article.

7

Cancer Immunology and Cancer Immunodiagnosis 2016.

Zhang J, Zhang B, Zhang Y. Zhang J, et al. Among authors: zhang b, zhang y. J Immunol Res. 2017;2017:9127382. doi: 10.1155/2017/9127382. Epub 2017 Jan 10. J Immunol Res. 2017. PMID: 28164138 Free PMC article. No abstract available.

8

Immunotherapy with CAR-Modified T Cells: Toxicities and Overcoming Strategies.

Sun S, Hao H, Yang G, Zhang Y, Fu Y. Sun S, et al. Among authors: zhang y. J Immunol Res. 2018 Apr 17;2018:2386187. doi: 10.1155/2018/2386187. eCollection 2018. J Immunol Res. 2018. PMID: 29850622 Free PMC article. Review.

9

miR-143 Regulates Memory T Cell Differentiation by Reprogramming T Cell Metabolism.

Zhang T, Zhang Z, Li F, Ping Y, Qin G, Zhang C, Zhang Y. Zhang T, et al. Among authors: zhang c, zhang z, zhang y. J Immunol. 2018 Oct 1;201(7):2165-2175. doi: 10.4049/jimmunol.1800230. Epub 2018 Aug 27. J Immunol. 2018. PMID: 30150287

10

Type 2 Innate Lymphoid Cells Impede IL-33-Mediated Tumor Suppression.

Long A, Dominguez D, Qin L, Chen S, Fan J, Zhang M, Fang D, Zhang Y, Kuzel TM, Zhang B. Long A, et al. Among authors: zhang m, zhang b, zhang y. J Immunol. 2018 Dec 1;201(11):3456-3464. doi: 10.4049/jimmunol.1800173. Epub 2018 Oct 29. J Immunol. 2018. PMID: 30373846 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

239,111 results

Search Page